These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characterization of the negative regulatory element of the 5' noncoding region of Moloney murine leukemia virus in mouse embryonal carcinoma cells. Tsukiyama T; Niwa O; Yokoro K Virology; 1990 Aug; 177(2):772-6. PubMed ID: 2371781 [TBL] [Abstract][Full Text] [Related]
8. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. Grez M; Zörnig M; Nowock J; Ziegler M J Virol; 1991 Sep; 65(9):4691-8. PubMed ID: 1870196 [TBL] [Abstract][Full Text] [Related]
9. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers. Thiesen HJ; Bösze Z; Henry L; Charnay P J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Hilberg F; Stocking C; Ostertag W; Grez M Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5232-6. PubMed ID: 3037539 [TBL] [Abstract][Full Text] [Related]
12. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Speck NA; Baltimore D Mol Cell Biol; 1987 Mar; 7(3):1101-10. PubMed ID: 3561410 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells. Tsukiyama T; Niwa O; Yokoro K Mol Cell Biol; 1989 Nov; 9(11):4670-6. PubMed ID: 2601693 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells. Loh TP; Sievert LL; Scott RW Mol Cell Biol; 1990 Aug; 10(8):4045-57. PubMed ID: 2370861 [TBL] [Abstract][Full Text] [Related]
15. Retroviral mutants efficiently expressed in embryonal carcinoma cells. Franz T; Hilberg F; Seliger B; Stocking C; Ostertag W Proc Natl Acad Sci U S A; 1986 May; 83(10):3292-6. PubMed ID: 3010288 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the binding proteins and activity of the long terminal repeat of Moloney murine leukemia virus during differentiation of mouse embryonal carcinoma cells. Tsukiyama T; Niwa O; Yokoro K J Virol; 1991 Jun; 65(6):2979-86. PubMed ID: 2033663 [TBL] [Abstract][Full Text] [Related]
17. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Speck NA; Renjifo B; Golemis E; Fredrickson TN; Hartley JW; Hopkins N Genes Dev; 1990 Feb; 4(2):233-42. PubMed ID: 2338244 [TBL] [Abstract][Full Text] [Related]
18. Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. Weiher H; Barklis E; Ostertag W; Jaenisch R J Virol; 1987 Sep; 61(9):2742-6. PubMed ID: 3612950 [TBL] [Abstract][Full Text] [Related]
19. Negative regulation of retrovirus expression in embryonal carcinoma cells mediated by an intragenic domain. Loh TP; Sievert LL; Scott RW J Virol; 1988 Nov; 62(11):4086-95. PubMed ID: 3172339 [TBL] [Abstract][Full Text] [Related]
20. Isolation of embryonal carcinoma cell lines that express integrated recombinant genes flanked by the Moloney murine leukemia virus long terminal repeat. Taketo M; Gilboa E; Sherman MI Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2422-6. PubMed ID: 3857593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]